π™πšπ¦π›πšπ«π­ 𝐓𝐁 π„π±π©πžπ«π­π¬ 𝐕𝐒𝐬𝐒𝐭 𝐊𝐚𝐧𝐲𝐚𝐦𝐚 𝟏𝐬𝐭 π‹πžπ―πžπ₯ π‡π¨π¬π©π’π­πšπ₯

Recently, a team from #Zambart conducted a vital site visit to Kanyama First Level Hospital to assess critical challenges affecting in-patient care.

The primary focus was on the strain caused by pulmonary tuberculosis (PTB) and post tuberculosis lung disease (PTLD). The team toured the medical in-patent department to gain a first -hand view on bed space and the pressing need for oxygen cylinders and concentrators.

The team held productive discussions outlining immediate, intermediate, and long-term strategies to address the problems of PTB and PTLD.

The Kanyama team was led by Dr. Beene Wanga, Head- Clinical Care and Dr Singoyi Head of Department- Internal Medicine.

Zambart looks forward to collaborating with stakeholders to implement these interventions and strengthen the healthcare system.

The Zambart team consisted of Prof. Helen Ayles, Senior Researcher; Dr. Modupe Amofa-Sekyi, Sub-Investigator on CommuniTB Vaccine Study, Dr. Mohammed Limbada, Head of Epidemiology and Clinical Research (ECR); Dr. Theresa Muzyamba-Kaulule, EpiTB Study Manager; and Dr. Kondwelani Mateyo Research Fellow.